Andrey Baranovsky

751 total citations · 1 hit paper
7 papers, 452 citations indexed

About

Andrey Baranovsky is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Andrey Baranovsky has authored 7 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in Andrey Baranovsky's work include Liver Disease Diagnosis and Treatment (3 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). Andrey Baranovsky is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). Andrey Baranovsky collaborates with scholars based in Russia, Germany and Poland. Andrey Baranovsky's co-authors include Séverine Vermeire, Róbert Sike, Xavier Hébuterne, Robert Petryka, Stefan Schreiber, Xavier Roblin, Maria Wiśniewska‐Jarosińska, Adrian Goldiș, Maria Kłopocka and Tanja Kuehbacher and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Andrey Baranovsky

7 papers receiving 439 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

2016 344 citations Séverine Vermeire, Stefan Schreiber et al. The Lancet profile →

Peers

Andrey Baranovsky

GENET

EPIDE

IMMUN

ONCOL

RHEUM

Juan S. Lasa Argentina

Maria Weidinger Germany

Tomáš Vaňásek Czechia

Alexandre Aubourg France

A Fernández-Clotet Spain

DW Hommes Netherlands

Nele Esters Belgium

Joëlle Bonnet France

Bunei Iizuka Japan

S. Shevchuk Ukraine

Juan S. Lasa Argentina

Andrey Baranovsky

167 ×0.6

GENET

122 ×0.6

EPIDE

66 ×0.6

IMMUN

70 ×0.8

ONCOL

90 ×1.0

RHEUM

Citations per year, relative to Andrey Baranovsky Andrey Baranovsky (= 1×) peers Juan S. Lasa

Countries citing papers authored by Andrey Baranovsky

Since Specialization

Citations

This map shows the geographic impact of Andrey Baranovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Baranovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Baranovsky more than expected).

Fields of papers citing papers by Andrey Baranovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey Baranovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Baranovsky. The network helps show where Andrey Baranovsky may publish in the future.

Co-authorship network of co-authors of Andrey Baranovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Baranovsky. A scholar is included among the top collaborators of Andrey Baranovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Baranovsky. Andrey Baranovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Baranovsky, Andrey, et al.. (2022). Dry protein composite mixture enriched with calcium of dairy origin, in the dietary treatment of certain diseases of the digestive system accompanied by malabsorption syndrome. Research Repository Saint Petersburg State University (Saint Petersburg State University). 17(1). 4–13. 1 indexed citations

2.

Ивашкин, В. Т., et al.. (2019). Drug-Induced Liver Injuries (Clinical Guidelines for Physicians). SHILAP Revista de lepidopterología. 29(1). 101–131. 35 indexed citations

3.

Baranovsky, Andrey, et al.. (2019). Morbidity and Mortality Rates from Digestive Diseases in the RF Northwestern Federal District (NWFD) and Measures to Reduce Them. SHILAP Revista de lepidopterología. 29(1). 36–46. 13 indexed citations

4.

Baranovsky, Andrey, et al.. (2017). Epidemiological features of non-alcoholic fatty liver disease in the North-West region of Russia (Results of an open multicenter prospective study DIREG 2). Research Repository Saint Petersburg State University (Saint Petersburg State University). 12(2). 118–135. 11 indexed citations

5.

Vermeire, Séverine, Stefan Schreiber, Robert Petryka, et al.. (2016). Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. 389(10066). 266–275. 344 indexed citations breakdown →

6.

Andus, Tilo, Andrey Baranovsky, Ingolf Cascorbi, et al.. (2010). Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis. Inflammatory Bowel Diseases. 16(11). 1947–1956. 47 indexed citations

7.

Andus, Tilo, et al.. (2008). T1137 A Novel High Dose 1g Mesalamine Suppository (Salofalk®) Is As Efficacious As 500mg TID Suppositories in Mild to Moderate Active Ulcerative Proctitis: A Multicenter, Randomized Trial. Gastroenterology. 134(4). A–491. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact